Understanding how immune cells recognize insulin in type 1 diabetes
Evolution of B Lymphocyte Insulin Autoantigen Recognition in Type 1 Diabetes
This study is looking at how certain immune cells called B lymphocytes interact with insulin in type 1 diabetes, using mice to understand how these interactions change over time, which could help develop better treatments for people with diabetes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10997967 on NIH RePORTER |
What this research studies
This research investigates the role of B lymphocytes in type 1 diabetes (T1D) by examining how these immune cells recognize insulin and present it to other immune cells. The study uses a mouse model to explore the evolution of insulin-binding B lymphocytes and their impact on the progression of T1D. By analyzing the changes in B cell receptor (BCR) recognition of insulin over time, the research aims to identify factors that contribute to the heterogeneity of diabetes onset and response to immunotherapy. This knowledge could lead to improved immunotherapy strategies for T1D patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of developing type 1 diabetes or those recently diagnosed with the condition.
Not a fit: Patients with type 1 diabetes who are not at risk or have advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapies for type 1 diabetes, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in understanding immune responses in type 1 diabetes, but this specific approach to studying B lymphocyte evolution is relatively novel.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Bass, Lindsay Emma — Vanderbilt University
- Study coordinator: Bass, Lindsay Emma
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.